Treating depression in schizophrenia.
Lund
B C
BC
Perry
P J
PJ
Miller
D D
DD
D000928:Antidepressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003024:Clozapine / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015897:Comorbidity; D003866:Depressive Disorder / Q000188:drug therapy* / Q000453:epidemiology; D004347:Drug Interactions; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D012565:Schizophrenic Psychology; D055502:Secondary Prevention
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D005473:Fluoxetine; D003024:Clozapine